Black Diamond Therapeutic... (BDTX)

1.92

-0.09 (-4.48%)

At close: Mar 03, 2025, 3:59 PM

1.93

0.52%

After-hours: Mar 03, 2025, 07:59 PM EST

Black Diamond Therapeutics Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17
Net Income	-82.44M	-91.17M	-125.6M	-67.25M	-35.26M	-8.93M	-4.6M
Depreciation & Amortization	437K	508K	205K	52K	47K	44K	24K
Stock-Based Compensation	9.6M	12.2M	14.04M	7.76M	3.64M	64K	5K
Other Working Capital	3.09M	-7.67M	5.45M	3.97M	-991K	90K	1.8M
Other Non-Cash Items	2M	3.28M	2.01M	524K	6.43M	15K	66K
Deferred Income Tax	n/a	n/a	2.18M	1.73M	n/a	n/a	412K
Change in Working Capital	3.69M	-9.9M	7.02M	5.04M	463K	354K	1.74M
Operating Cash Flow	-66.72M	-85.08M	-100.15M	-52.15M	-24.67M	-8.45M	-2.35M
Capital Expenditures	-33K	-192K	-2.71M	-142K	-21K	-76K	-77K
Acquisitions	n/a	9K	2.7M	118K	n/a	n/a	n/a
Purchase of Investments	-61.89M	-60.14M	-49.51M	-372.48M	n/a	n/a	n/a
Sales Maturities Of Investments	78.17M	113.69M	182.83M	90.93M	n/a	n/a	n/a
Other Investing Acitivies	95K	53.56K	-2.7M	-118K	-21K	n/a	n/a
Investing Cash Flow	16.35M	53.37M	130.61M	-281.69M	-21K	-76K	-77K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	-50K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	164K	177K	729K	1.1M	127.76M	52.31M	19.95M
Financial Cash Flow	71.93M	177K	729K	214.94M	127.76M	52.31M	9.97M
Net Cash Flow	21.56M	-31.54M	31.19M	-118.89M	103.06M	43.78M	7.55M
Free Cash Flow	-66.75M	-85.27M	-102.86M	-52.29M	-24.7M	-8.53M	-2.43M